Upgrade to SI Premium - Free Trial

PolyPid Ltd. (PYPD)

4.62 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 6-K PolyPid Ltd. For: Jun 01 June 1, 2026 8:35 AM - SEC Filing PolyPid completes FDA submission for surgical infection prevention drug June 1, 2026 8:32 AM - StreetInsider PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ June 1, 2026 8:30 AM - StreetInsider PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference May 20, 2026 8:30 AM - Globe NewsWire Form 6-K PolyPid Ltd. For: May 13 May 13, 2026 7:35 AM - SEC Filing PolyPid Ltd. (PYPD) Tops Q1 EPS by 70c May 13, 2026 7:30 AM - StreetInsider PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results May 13, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G/A PolyPid Ltd. Filed by: Rosalind Advisors, Inc. May 12, 2026 11:25 AM - SEC Filing PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026 May 6, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A PolyPid Ltd. Filed by: Aurum Ventures M.K.I. Ltd. May 4, 2026 6:13 AM - SEC Filing PolyPid to present surgical infection data at medical conference April 28, 2026 8:30 AM - StreetInsider PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting April 28, 2026 8:30 AM - Globe NewsWire PolyPid to present D-PLEX100 trial data at ESCMID Global 2026 April 13, 2026 9:15 AM - StreetInsider PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026 April 13, 2026 9:15 AM - StreetInsider Form 3 PolyPid Ltd. For: Mar 18 Filed by: Jacobovitz Yitzchak Shlomo April 6, 2026 4:02 PM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Stein Robert Benjamin April 6, 2026 8:02 AM - SEC Filing Form 6-K PolyPid Ltd. For: Mar 31 March 31, 2026 8:35 AM - SEC Filing PolyPid begins FDA submission for surgical infection drug March 31, 2026 8:30 AM - StreetInsider PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA March 31, 2026 8:30 AM - StreetInsider Form 3 PolyPid Ltd. For: Mar 18 Filed by: Warshavsky Ori March 26, 2026 4:01 PM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Dror-Darwish Nir March 26, 2026 8:56 AM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Missulawin Jonathan March 23, 2026 4:01 PM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Barenholz Yechezkel March 23, 2026 8:06 AM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: BenAmram Joseph March 23, 2026 8:04 AM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Story Brooke March 18, 2026 4:03 PM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Krinsky Itzhak March 18, 2026 4:03 PM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Akselbrad Dikla Czaczkes March 18, 2026 4:02 PM - SEC Filing Form 3 PolyPid Ltd. For: Mar 18 Filed by: Hazan Dalit Fellous March 18, 2026 4:02 PM - SEC Filing PolyPid receives $4.3 million FDA fee waiver for drug application March 17, 2026 8:30 AM - StreetInsider PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application March 17, 2026 8:30 AM - StreetInsider Full Article List